Singleron Biotechnologies

company

About

Singleron Biotechnologies is an innovative molecular diagnostic company.

  • 101 - 250

Details

Last Funding Type
Series A
Last Funding Money Raised
$30M
Industries
Biotechnology
Founded date
Jan 1, 2018
Number Of Employee
101 - 250
Operating Status
Active

Singleron Biotechnologies is a developer and provider of clinical diagnosis, health management and drug development products and services. The company is dedicated to applying single cell analysis techniques and has obtained a world wide exclusive IP license from Yale University for its uniquely designed microfluidic single cell processing device, and has developed the innovative SCOPE single-cell pre-sequencing preparation system based on this microfluidic device.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$130M
Singleron Biotechnologies has raised a total of $130M in funding over 2 rounds. Their latest funding was raised on Nov 10, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 10, 2021 Series B $100M 2 Detail
Sep 6, 2020 Series A $30M 2 Lilly Asia Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Singleron Biotechnologies is funded by 2 investors. ARCH Venture Partners and Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Series B
Lilly Asia Ventures Series B